✦ LIBER ✦

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies

✍ Scribed by Toi, M; Iwata, H; Fujiwara, Y; Ito, Y; Nakamura, S; Tokuda, Y; Taguchi, T; Rai, Y; Aogi, K; Arai, T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, pharmacokinetics and b

✍ Iwata, Hiroji; Fujii, Hirofumi; Masuda, Norikazu; Mukai, Hirofumi; Nishimura, Yu 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 300 KB

SU11248 (sunitinib malate) therapy in pa

✍ K.D. Miller; Burstein; A.D. Elias; H.S. Rugo; M.A. Cobleigh; A.C. Wolff; P.D. Ei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

A phase II study of pemetrexed and carbo

✍ August Garin; Alexey Manikhas; Mikhail Biakhov; Mikhail Chezhin; Tatiana Ivanche 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 195 KB

Lapatinib monotherapy in patients with H

✍ Bella Kaufman; Maureen Trudeau; Ahmad Awada; Kimberly Blackwell; Thomas Bachelot 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 500 KB

Results of a phase II study of pemetrexe

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB

Phase I/II Pharmacokinetic Study of Peme

✍ Robert Paridaens; Luc Dirix; Herlinde Dumez; Annemie Prové; Hans Wildiers; Ana A 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 110 KB